Research Article

Protective and therapeutic effects of hesperidin in an experimental colitis model

Volume: 11 Number: 4 November 3, 2024
TR EN

Protective and therapeutic effects of hesperidin in an experimental colitis model

Abstract

Ulcerative colitis is a gastrointestinal problem with increasing prevalence. In this study, the effect of hesperidin (commonly found in citrus white peel) on colitis was investigated. For this purpose, 28 Wistar albino female rats, 3–4 months old and weighing between 250–350 g, were used in the study. Rats were randomly divided into four groups: control (n=7), colitis (n=7), protective effect (n=7), and treatment (n=7) groups. Colitis was induced in rats with acetic acid (except control), and hesperidin was then administered at 150 mg/kg for 1 week before and after colitis. At the end of the study, IFN-γ and IL-6 values in blood, TAS, TOS, and OSI in tissue were evaluated. Intestinal tissues were assessed visually by haematoxylin and eosin staining. Our results showed that the levels of IFN-γ and IL-6 were highest in the colitis group and lowest in the treatment group, with statistical significance. The most histopathological damage was seen in the colitis group, while less prevalent in the treatment and control groups. The results of the study show that hesperidin had limited protective and therapeutic effects on experimental colitis mouse models.

Keywords

Supporting Institution

ADNAN MENDERES ÜNİVERSİTY

Project Number

Aydın Adnan Menderes University Scientific Research Projects Unit with project number SBF-22005.

Ethical Statement

Adnan Menderes Üniversitesi Hayvan Deneyleri Yerel Etik Kurulu (Adü-Hadyek)’ndan alınmıştır (Tarih ve Sayı: 20.09.2021, 64583101/2021/140)

Thanks

We thank Aydin Adnan Menderes University for all its technical infrastructure and financial support.

References

  1. Crespo, M.E., Calvez, J., Cruz, T., & Ocete, M.A. (1999). Anti-inflammatory activity of diosmin and hesperidin in rat colitis induced by TNBS. Planta Medica, 65, 651-653. https://doi.org/10.1055/s-2006-960838
  2. Erel, O. (2004). A novel automated method to measure total antioxidant response against potent free radical reactions. Clinical Biochemistry, 37(2), 112 119. https://doi.org/10.1016/j.clinbiochem.2003.10.014
  3. Erel, O. (2005). A new automated colourimetric method for measuring total oxidant status. Clinical Biochemistry, 38(12):1103-11. https://doi.org/10.1016/j.clinbiochem.2005.08.008
  4. Funakashi, K., Sugimura, K., Anezaki, K., Bannai, H., & Asakura, H. (1998). Spectrum of cytokines gene expression in intestinal mucosal lesions of Crohn’s disease and ulcerative colitis. Digestion, 59(1), 73-78 https://doi.org/10.1159/000007470
  5. Galipeau, H.J., Caminero, A., Turpin, W., Bermudez-Brito, M., Santiago, A., Libertucci, J., & Verdu, E.F. (2021). Novel fecal biomarkers that precede clinical diagnosis of ulcerative colitis. Journal of Gastroenterology, 160(5), 1532 1545. https://doi.org/10.1053/j.gastro.2020.12.004
  6. Lu Q, Yang M. F, Liang Y.J, Xu J., Xu H.M, Nie Y.Q, Wang L.S., Yao J., & Li D.F. (2022). Immunology of Inflammatory Bowel Disease: Molecular Mechanisms and Therapeutics. Journal of Inflammation Research, 15, 1825–1844. https://doi.org/10.2147/JIR.S353038
  7. Murata Y, Ishiguro Y, Itoh J, Munakata, A., Yoshida, Y. (1995). The role of proinflammatory and immunoregulatory cytokines in the pathogenesis of ulcerative colitis. Journal of Gastroenterology, 8, 56-60.
  8. Nazlıkul, H. (2020). İnflamatuvar bağırsak hastalığı regülasyon tıbbı nöralterapı̇ yaklaşımı. [Inflammatory intestinal disease regulation medicine; neuraltherapy approach]. Bilimsel Tamamlayıcı Tıp Regülasyon ve Nöral Terapi Dergisi, 14(3), 80-92.

Details

Primary Language

English

Subjects

Pharmaceutical Botany, Pharmaceutical Toxicology

Journal Section

Research Article

Early Pub Date

October 8, 2024

Publication Date

November 3, 2024

Submission Date

February 2, 2024

Acceptance Date

August 14, 2024

Published in Issue

Year 2024 Volume: 11 Number: 4

APA
Güzel, E., Öğüt, S., & Aktaş, S. (2024). Protective and therapeutic effects of hesperidin in an experimental colitis model. International Journal of Secondary Metabolite, 11(4), 795-801. https://doi.org/10.21448/ijsm.1430630
AMA
1.Güzel E, Öğüt S, Aktaş S. Protective and therapeutic effects of hesperidin in an experimental colitis model. Int. J. Sec. Metabolite. 2024;11(4):795-801. doi:10.21448/ijsm.1430630
Chicago
Güzel, Esra, Serdal Öğüt, and Serdar Aktaş. 2024. “Protective and Therapeutic Effects of Hesperidin in an Experimental Colitis Model”. International Journal of Secondary Metabolite 11 (4): 795-801. https://doi.org/10.21448/ijsm.1430630.
EndNote
Güzel E, Öğüt S, Aktaş S (November 1, 2024) Protective and therapeutic effects of hesperidin in an experimental colitis model. International Journal of Secondary Metabolite 11 4 795–801.
IEEE
[1]E. Güzel, S. Öğüt, and S. Aktaş, “Protective and therapeutic effects of hesperidin in an experimental colitis model”, Int. J. Sec. Metabolite, vol. 11, no. 4, pp. 795–801, Nov. 2024, doi: 10.21448/ijsm.1430630.
ISNAD
Güzel, Esra - Öğüt, Serdal - Aktaş, Serdar. “Protective and Therapeutic Effects of Hesperidin in an Experimental Colitis Model”. International Journal of Secondary Metabolite 11/4 (November 1, 2024): 795-801. https://doi.org/10.21448/ijsm.1430630.
JAMA
1.Güzel E, Öğüt S, Aktaş S. Protective and therapeutic effects of hesperidin in an experimental colitis model. Int. J. Sec. Metabolite. 2024;11:795–801.
MLA
Güzel, Esra, et al. “Protective and Therapeutic Effects of Hesperidin in an Experimental Colitis Model”. International Journal of Secondary Metabolite, vol. 11, no. 4, Nov. 2024, pp. 795-01, doi:10.21448/ijsm.1430630.
Vancouver
1.Esra Güzel, Serdal Öğüt, Serdar Aktaş. Protective and therapeutic effects of hesperidin in an experimental colitis model. Int. J. Sec. Metabolite. 2024 Nov. 1;11(4):795-801. doi:10.21448/ijsm.1430630

Cited By

International Journal of Secondary Metabolite

e-ISSN: 2148-6905